BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program

  September 11, 2025

   · 

  5 min read
• Press Releases

  PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations

  September 11, 2025

   · 

  5 min read
• Press Releases

  C-Ray Therapeutics Supports Mednovo’s Phase III Clinical Trial with First Patient Dosed for Lutetium [177Lu] Oxodotreotide Injection

  September 11, 2025

   · 

  4 min read
• Press Releases

  neurocare group’s Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression

  September 11, 2025

   · 

  3 min read
• Press Releases

  Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities

  September 11, 2025

   · 

  4 min read
• Press Releases

  Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

  September 11, 2025

   · 

  6 min read
• Press Releases

  FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

  September 11, 2025

   · 

  4 min read
• Press Releases

  Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi’s Long-Acting Injectable Platform

  September 11, 2025

   · 

  3 min read
• Press Releases

  Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms

  September 11, 2025

   · 

  6 min read
• Press Releases

  Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock

  September 11, 2025

   · 

  3 min read